Risks Associated With the Non-Medicinal Use of Cannabis

被引:80
作者
Hoch, Eva [1 ]
Bonnet, Udo [2 ]
Thomasius, Rainer [3 ]
Ganzer, Florian [3 ]
Havemann-Reinecke, Ursula [4 ,5 ,6 ]
Preuss, Ulrich W. [7 ,8 ]
机构
[1] Heidelberg Univ, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, D-69115 Heidelberg, Germany
[2] Univ Duisburg Essen, Dept Psychiat Psychotherapy & Psychosomat Med, Evangel Krankenhaus Castrop Rauxel, Teaching Hosp, Essen, Germany
[3] Univ Hosp Hamburg Eppendorf, German Ctr Addict Res Childhood & Adolescence DZS, Hamburg, Germany
[4] Univ Gottingen, Dept Psychiat & Psychotherapy, Fac Med, Gottingen, Germany
[5] Univ Med Ctr Gottingen, DFG Res Ctr, Gottingen, Germany
[6] Univ Med Ctr Gottingen, Cluster Excellence Nanoscale Microscopy & Mol Phy, Gottingen, Germany
[7] Kreiskrankenhaus Prignitz, Dept Psychiat Psychotherapy & Psychosomat Med, Perleberg, Germany
[8] Univ Halle Wittenberg, Dept Psychiat Psychotherapy & Psychosomat Med, D-06108 Halle, Saale, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2015年 / 112卷 / 16期
关键词
USE DISORDERS; SUICIDAL BEHAVIORS; TREATMENT PROGRAM; BIPOLAR DISORDER; MARIJUANA USE; LUNG-CANCER; WITHDRAWAL; SMOKING; INTERVENTIONS; ABSTINENCE;
D O I
10.3238/arztebl.2015.0271
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cannabis is the most commonly consumed illicit drug around the world; in Germany, about 4.5% of all adults use it each year. Intense cannabis use is associated with health risks. Evidence-based treatments are available for health problems caused by cannabis use. Methods: Selective literature review based on a search of the PubMed database, with special emphasis on systematic reviews, meta-analyses, cohort studies, randomized controlled trials (RCTs), case-control studies, and treatment guidelines. Results: The delta-9-tetrahydrocannabinol content of cannabis products is rising around the world as a result of plant breeding, while cannabidiol, in contrast, is often no longer detectable. Various medical conditions can arise acutely after cannabis use, depending on the user's age, dose, frequency, mode and situation of use, and individual disposition; these include panic attacks, psychotic symptoms, deficient attention, impaired concentration, motor incoordination, and nausea. In particular, intense use of high doses of cannabis over many years, and the initiation of cannabis use in adolescence, can be associated with substance dependence (DSM-5; ICD-10), specific withdrawal symptoms, cognitive impairment, affective disorders, psychosis, anxiety disorders, and physical disease outside the brain (mainly respiratory and cardiovascular conditions). At present, the most effective way to treat cannabis dependence involves a combination of motivational encouragement, cognitive behavioral therapy, and contingency management (level 1a evidence). For adolescents, family therapy is also recommended (level 1a evidence). No pharmacological treatments can be recommended to date, as evidence for their efficacy is lacking. Conclusion: Further research is needed to elucidate the causal relationships between intense cannabis use and potential damage to physical and mental health. Health problems due to cannabis use can be effectively treated.
引用
收藏
页码:271 / +
页数:12
相关论文
共 50 条
[41]   Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions [J].
Woo, Julia J. ;
van Reekum, Emma A. ;
Rosic, Tea ;
Samaan, Zainab .
ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2020, 11 :53-61
[42]   The burden of disease attributable to cannabis use in Canada in 2012 [J].
Imtiaz, Sameer ;
Shield, Kevin D. ;
Roerecke, Michael ;
Cheng, Joyce ;
Popova, Svetlana ;
Kurdyak, Paul ;
Fischer, Benedikt ;
Rehm, Juergen .
ADDICTION, 2016, 111 (04) :653-662
[43]   Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease [J].
Benson, Melissa J. ;
Abelev, Sarah, V ;
Corte, Crispin J. ;
Connor, Susan J. ;
McGregor, Iain S. .
CROHNS & COLITIS 360, 2020, 2 (02)
[44]   Conceptualizing problematic use of medicinal Cannabis: Development and preliminary validation of a brief screening questionnaire [J].
Feingold, Daniel ;
Gliksberg, Or ;
Brill, Silviu ;
Amit, Ben H. ;
Lev-Ran, Shaul ;
Kushnir, Talma ;
Sznitman, Sharon R. .
ADDICTIVE BEHAVIORS, 2024, 158
[45]   Goal commitment predicts cannabis use for adolescents in treatment [J].
Kaminer, Yifrah ;
Ohannessian, Christine M. ;
Burke, Rebecca H. .
SUBSTANCE ABUSE, 2019, 40 (04) :496-500
[46]   The relationship between motivations for cannabis consumption and problematic use [J].
Casajuana-Kogel, Cristina ;
Lopez-Pelayo, Hugo ;
Oliveras, Clara ;
Colom, Joan ;
Gual, Antoni ;
Mercedes Balcells-Olivero, Maria .
ADICCIONES, 2021, 33 (01) :31-41
[47]   Cannabis and nicotine co-use among primary care patients in a state with legal cannabis access [J].
McClure, Erin A. ;
Hamilton, Leah ;
Schauer, Gillian L. ;
Matson, Theresa E. ;
Lapham, Gwen T. .
ADDICTIVE BEHAVIORS, 2023, 140
[48]   Cannabis Use Is Associated with Prevalent Angina in Individuals with Diabetes [J].
Skipina, Travis M. ;
Upadhya, Bharathi ;
Soliman, Elsayed Z. .
CANNABIS AND CANNABINOID RESEARCH, 2023, 8 (04) :679-683
[49]   Cannabis use is associated with prevalent coronary artery disease [J].
Skipina, Travis M. ;
Patel, Nikhil ;
Upadhya, Bharathi ;
Soliman, Elsayed Z. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 364 (03) :304-308
[50]   Cannabis use and its associated disorders: Clinical care [J].
Copeland, Jan .
AUSTRALIAN FAMILY PHYSICIAN, 2016, 45 (12) :874-877